Carmignac Gestion Bio N Tech Se Transaction History
Carmignac Gestion
- $5.85 Billion
- Q1 2025
A detailed history of Carmignac Gestion transactions in Bio N Tech Se stock. As of the latest transaction made, Carmignac Gestion holds 185,877 shares of BNTX stock, worth $19.8 Million. This represents 0.29% of its overall portfolio holdings.
Number of Shares
185,877
Previous 222,095
16.31%
Holding current value
$19.8 Million
Previous $25.3 Million
33.12%
% of portfolio
0.29%
Previous 0.41%
Shares
4 transactions
Others Institutions Holding BNTX
# of Institutions
340Shares Held
40MCall Options Held
1.43MPut Options Held
1.54M-
Baillie Gifford & CO8.16MShares$868 Million0.67% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.26MShares$453 Million1.71% of portfolio
-
Primecap Management CO Pasadena, CA4.05MShares$430 Million0.31% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$202 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$192 Million0.84% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $25.8B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...